287 related articles for article (PubMed ID: 15189963)
1. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
Kwek BH; Aquino SL; Fischman AJ
Chest; 2004 Jun; 125(6):2356-60. PubMed ID: 15189963
[TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
Nguyen NC; Tran I; Hueser CN; Oliver D; Farghaly HR; Osman MM
Clin Nucl Med; 2009 Dec; 34(12):886-90. PubMed ID: 20139823
[TBL] [Abstract][Full Text] [Related]
3. CT appearances of talc pleurodesis.
Narayanaswamy S; Kamath S; Williams M
Clin Radiol; 2007 Mar; 62(3):233-7. PubMed ID: 17293216
[TBL] [Abstract][Full Text] [Related]
4. Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography/computed tomography.
Weiss N; Solomon SB
Clin Nucl Med; 2003 Oct; 28(10):811-4. PubMed ID: 14508271
[TBL] [Abstract][Full Text] [Related]
5. False positive 18F-FDG-PET/CT in a patient after talc pleurodesis.
Ahmadzadehfar H; Palmedo H; Strunk H; Biersack HJ; Habibi E; Ezziddin S
Lung Cancer; 2007 Dec; 58(3):418-21. PubMed ID: 17624474
[TBL] [Abstract][Full Text] [Related]
6. [Radiological changes of talc pleurodesis in cases of effusion].
Carignan S; Samson L; Lafontaine E; Cordeau MP
Ann Chir; 1994; 48(8):777-84. PubMed ID: 7872630
[TBL] [Abstract][Full Text] [Related]
7. Talc Pleurodesis With Intense 18F-FDG Activity But No 68Ga-DOTA-TATE Activity on PET/CT.
Papadakis GZ; Millo C; Bagci U; Patronas NJ; Stratakis CA
Clin Nucl Med; 2015 Oct; 40(10):819-20. PubMed ID: 26018715
[TBL] [Abstract][Full Text] [Related]
8. Histology of the pleural rind at [
Soltermann A; Opitz I; Burger IA
Pathol Res Pract; 2021 Dec; 228():153660. PubMed ID: 34749212
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.
Cardillo G; Facciolo F; Carbone L; Regal M; Corzani F; Ricci A; Di Martino M; Martelli M
Eur J Cardiothorac Surg; 2002 Feb; 21(2):302-5; discussion 305-6. PubMed ID: 11825740
[TBL] [Abstract][Full Text] [Related]
10. Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma.
Vandemoortele T; Laroumagne S; Roca E; Bylicki O; Dales JP; Dutau H; Astoul P
Respiration; 2014; 87(3):243-8. PubMed ID: 24457915
[TBL] [Abstract][Full Text] [Related]
11. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway.
Ahmed L; Ip H; Rao D; Patel N; Noorzad F
Chest; 2014 Dec; 146(6):e190-e194. PubMed ID: 25451360
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pleural lesions after pleurodesis with OK-432 by fluorodeoxyglucose-positron emission tomography/CT.
Nishimori M; Yoshimatsu R; Iwasa H; Miyatake K; Nitta N; Anayama T; Yamagami T
Ann Nucl Med; 2020 Oct; 34(10):793-798. PubMed ID: 32809160
[TBL] [Abstract][Full Text] [Related]
13. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Pilling J; Dartnell JA; Lang-Lazdunski L
Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.
Kitajima K; Nakamichi T; Hasegawa S; Kuribayashi K; Yamakado K
Cureus; 2018 Nov; 10(11):e3654. PubMed ID: 30723653
[TBL] [Abstract][Full Text] [Related]
15. CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis.
Avila NA; Dwyer AJ; Rabel A; DeCastro RM; Moss J
AJR Am J Roentgenol; 2006 Apr; 186(4):1007-12. PubMed ID: 16554571
[TBL] [Abstract][Full Text] [Related]
16. Lung Nodule with Increasing Fluorodeoxyglucose Uptake in a Patient with a History of Lung Carcinoma and Talc Pleurodesis Evaluated by EBUS-TBNA On-Site Assessment.
Kurian EM
Acta Cytol; 2017; 61(1):84-86. PubMed ID: 28110329
[TBL] [Abstract][Full Text] [Related]
17. Talc pleurodesis in pleuropulmonary diseases treatment.
Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
[TBL] [Abstract][Full Text] [Related]
18. Intense pleural FDG uptake 12 years after talc pleurodesis: PET/CT findings.
Gorospe Sarasúa L; Jover-Díaz R; Arrieta P
Arch Bronconeumol; 2017 Nov; 53(11):638. PubMed ID: 28554586
[No Abstract] [Full Text] [Related]
19. CT appearance of the pleural space after talc pleurodesis.
Murray JG; Patz EF; Erasmus JJ; Gilkeson RC
AJR Am J Roentgenol; 1997 Jul; 169(1):89-91. PubMed ID: 9207506
[TBL] [Abstract][Full Text] [Related]
20. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
